Clinical Outcomes and Prognostic Factors Following Routine CT-Based Image-Guided Adaptive Brachytherapy for Cervical Cancer: A Retrospective Cohort Study
Authors:
- Pooriwat MuangwongPMPooriwat Muangwong
- Ekkasit TharavichitkulETEkkasit Tharavichitkul
- Somvilai ChakrabandhuSCSomvilai Chakrabandhu
- Pitchayaponne KlunklinPKPitchayaponne Klunklin
- Wimrak OnchanWOWimrak Onchan
- Bongkot Jia-MahasapBJBongkot Jia-Mahasap
- Piyapasara ToapichattrakulPTPiyapasara Toapichattrakul
- Wannapha NobnopWNWannapha Nobnop
- Anirut WatcharawiphaAWAnirut Watcharawipha
- Razvan M. GalalaeRGRazvan M. Galalae
- Imjai ChitapanaruxICImjai Chitapanarux
Open Access
Abstract
Background/Objectives: Magnetic resonance imaging (MRI)-based image-guided adaptive brachytherapy (IGABT) is the preferred standard for cervical cancer, but access remains limited in many settings. Computed tomography (CT)-based IGABT provides a practical alternative. We evaluated clinical outcomes and prognostic factors following its routine implementation. Methods: This retrospective cohort study included patients with International Federation of Gynecology and Obstetrics (FIGO) 2018 stage I–IVA cervical carcinoma treated with definitive radiotherapy incorporating CT-based IGABT from January 2019 to December 2021. Patients received pelvic external beam radiotherapy (45–50.4 Gy in 23–28 fractions), with or without concurrent platinum-based chemotherapy, followed by four high-dose-rate brachytherapy fractions. Local control and overall survival were estimated using Kaplan–Meier analysis, and prognostic factors were evaluated using Cox regression. Results: Among 237 patients, 56.9% had FIGO stage III–IV disease, and hybrid intracavitary/interstitial brachytherapy was used in 30.2% of fractions. The mean high-risk clinical target volume D90 (HR-CTV D90) was 85.4 ± 2.7 Gy EQD2. Median follow-up was 59.9 months for local control and 71.1 months for overall survival. The 5-year local control and overall survival rates were 84.4% (95% CI, 79.1–88.5%) and 62.9% (95% CI, 56.3–68.8%), respectively. Squamous histology was independently associated with improved local control and overall survival. HR-CTV D90 ≥ 85 Gy EQD2 was associated with improved local control, whereas ≥4 chemotherapy cycles and overall treatment time ≤ 56 days were associated with improved overall survival. Conclusions: Routine CT-based IGABT achieved clinically meaningful outcomes despite the high proportion of advanced-stage disease. Achieving HR-CTV D90 ≥ 85 Gy EQD2, delivering ≥4 chemotherapy cycles, and completing treatment within 56 days were associated with improved outcomes.Keywords
This publication has 31 references indexed in Scilit:
- CT versus MRI for Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: A Propensity Score–Matched AnalysisInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2026
- Whole-uterine versus individualized-uterine radiotherapy in locally advanced cervical cancer: clinical outcome and toxicityInternational Journal of Gynecological Cancer, 2025
- Image guided cervical brachytherapy practice patterns: 2023/2024 survey of the American brachytherapy societyBrachytherapy, 2024
- Clinical Outcome Comparison between CT-Guided Versus all MRI-Guided Scenarios in Brachytherapy for Cervical Cancer: A Single-Institute ExperienceClinical Oncology, 2024
- Updated Trends in the Utilization of Brachytherapy in Cervical Cancer in the United States: A Surveillance, Epidemiology, and End-Results StudyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2023
- CT-based image-guided brachytherapy in uterine cervical cancer: Effect of tumor dose and volume on local controlBrachytherapy, 2022
- Cancer of the cervix uteri: 2021 updateInternational Journal of Gynecology & Obstetrics, 2021
- Cancer of the cervix uteriInternational Journal of Gynecology & Obstetrics, 2018
- Comparison and Consensus Guidelines for Delineation of Clinical Target Volume for CT- and MR-Based Brachytherapy in Locally Advanced Cervical CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2014
- Computed Tomography Versus Magnetic Resonance Imaging-Based Contouring in Cervical Cancer Brachytherapy: Results of a Prospective Trial and Preliminary Guidelines for Standardized ContoursInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007